Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Sertié JA et al. | Pharmacological assay of Cordia verbenacea V: oral and topical anti-inflammatory activity, analgesic effect and fetus toxicity of a crude leaf extract. | 2005 | Phytomedicine | pmid:15957367 |
Ahua KM et al. | Antileishmanial and antifungal acridone derivatives from the roots of Thamnosma rhodesica. | 2004 | Phytochemistry | pmid:15081302 |
Valitova JN et al. | Effects of sterol-binding agent nystatin on wheat roots: the changes in membrane permeability, sterols and glycoceramides. | 2011 | Phytochemistry | pmid:21726881 |
Joseph-Horne T et al. | Nonsterol related resistance in Ustilago maydis to the polyene antifungals, amphotericin B and nystatin. | 1996 | Phytochemistry | pmid:8768319 |
Dos Santos AG et al. | The molecular mechanism of Nystatin action is dependent on the membrane biophysical properties and lipid composition. | 2017 | Phys Chem Chem Phys | pmid:29098221 |
Arrigoni-Martelli E et al. | The influence of anti-inflammatory and immunosuppressant drugs on Nystatin induced oedema. | 1971 | Pharmacology | pmid:5088647 |
Wasan KM et al. | A comparison of step-gradient and sequential density ultracentrifugation and the use of lipoprotein deficient plasma controls in determining the plasma lipoprotein distribution of lipid-associated nystatin and cyclosporine. | 1999 | Pharm. Res. | pmid:9950297 |
Mohammadi G et al. | Preparation, Physicochemical Characterization and Anti-fungal Evaluation of Nystatin-Loaded PLGA-Glucosamine Nanoparticles. | 2017 | Pharm. Res. | pmid:27928646 |
Vermerie N et al. | Stability of nystatin in mouthrinses; effect of pH temperature, concentration and colloidal silver addition, studied using an in vitro antifungal activity. | 1997 | Pharm World Sci | pmid:9297733 |
Sakeer K et al. | Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets. | 2010 Jul-Aug | Pharm Dev Technol | pmid:19772376 |
Silva FC et al. | Nystatin and lidocaine pastilles for the local treatment of oral mucositis. | 2017 | Pharm Dev Technol | pmid:27499389 |
Pinto Reis C et al. | Innovative formulation of nystatin particulate systems in toothpaste for candidiasis treatment. | 2016 | Pharm Dev Technol | pmid:25567611 |
Wu J and Partridge LD | Dissociated dopaminergic neurons from substantia nigra zona compacta in young rats lack functional NMDA receptors. | 1998 | Pflugers Arch. | pmid:9479023 |
Thodis E et al. | Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. | 1998 Nov-Dec | Perit Dial Int | pmid:9932656 |
Williams PF et al. | No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients. | 2000 May-Jun | Perit Dial Int | pmid:10898060 |
Lye WC | Nystatin prophylaxis for fungal peritonitis: to be or not to be? | 2007 Sep-Oct | Perit Dial Int | pmid:17704437 |
Wong PN et al. | Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. | 2007 Sep-Oct | Perit Dial Int | pmid:17704443 |
Robitaille P et al. | Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience. | 1995 | Perit Dial Int | pmid:7734569 |
Lo WK and Cheng IK | Who is going to benefit from nystatin prophylaxis for fungal peritonitis complicating CAPD? | 1999 Mar-Apr | Perit Dial Int | pmid:10357198 |
Davis TC | Chronic vulvovaginitis in children due to Shigella flexneri. | 1975 | Pediatrics | pmid:1098002 |